HRID366427

反应详情

EQUATION

反应方程式

REACTANTS

反应物

HCID2735936

Piperazine, 1-(10,11-dihydrodibenzo(a,d)cyclohepten-5-yl)-

C19H22N2

$结构：ClC/C=C\CCl$

HCID6432115

(2Z)-1,4-Dichlorobut-2-ene

C4H6Cl2

$结构：Cc1nc2cccc(OC/C=C\Cl)c2s1$

HCID86755936

未命名化合物

PRODUCTS

生成物

$结构：Cc1nc2cccc(OC/C=C\CN3CCN(C4c5ccccc5CCc5ccccc54)CC3)c2s1$

HCID67851631

未命名化合物

$结构：Cc1nc2cccc(OC/C=C\Cl)c2s1$

HCID86755936

未命名化合物

PROCEDURE

实验过程

The title compound was prepared according to Method GA from cis-7-(3-chloroallyloxy)-2-methyl-benzothiazole and 1-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)piperazine. mp 114° C.; LSIMS m/z 496. The cis-7-(3-chloro-allyloxy)-2-methyl-benzothiazole was prepared by Method IV, with cis-1,4-dichloro-2-butene as the alkylating agent.

来源与证据

来源类型: Open Reaction Database
ORD 记录: ord-e00a9f5c77f841b29a420b447aaf9417
来源数据集: uspto-grants-2000_10
DOI: 10.6084/m9.figshare.5104873.v1
专利: US06130217
来源说明: uspto-grants-2000_10

反应 SMILES

[Cl:1]/[CH:2]=[CH:3]\[CH2:4][O:5][C:6]1[C:14]2[S:13][C:12]([CH3:15])=[N:11][C:10]=2[CH:9]=[CH:8][CH:7]=1.[CH:16]1[C:26]2[CH2:25][CH2:24][C:23]3[CH:27]=[CH:28][CH:29]=[CH:30][C:22]=3[CH:21]([N:31]3[CH2:36][CH2:35][NH:34][CH2:33][CH2:32]3)[C:20]=2[CH:19]=[CH:18][CH:17]=1.Cl[CH2:38]/C=C\CCl>>[CH:27]1[C:23]2[CH2:24][CH2:25][C:26]3[CH:16]=[CH:17][CH:18]=[CH:19][C:20]=3[CH:21]([N:31]3[CH2:32][CH2:33][N:34]([CH2:38]/[CH:2]=[CH:3]\[CH2:4][O:5][C:6]4[C:14]5[S:13][C:12]([CH3:15])=[N:11][C:10]=5[CH:9]=[CH:8][CH:7]=4)[CH2:35][CH2:36]3)[C:22]=2[CH:30]=[CH:29][CH:28]=1.[Cl:1]/[CH:2]=[CH:3]\[CH2:4][O:5][C:6]1[C:14]2[S:13][C:12]([CH3:15])=[N:11][C:10]=2[CH:9]=[CH:8][CH:7]=1